Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study.

Autor:	Ismael NE; Faculty of Medicine, Cairo University, Cairo, Egypt., El Sheikh SA; Faculty of Medicine, Cairo University, Cairo, Egypt., Talaat SM; Ahmed Maher Teaching Hospital, Cairo, Egypt., Salem EM; Ahmed Maher Teaching Hospital, Cairo, Egypt.
Jazyk:	angličtina
Zdroj:	Open access Macedonian journal of medical sciences [Open Access Maced J Med Sci] 2017 Mar 15; Vol. 5 (1), pp. 9-13. Date of Electronic Publication: 2017 Feb 12.
DOI:	10.3889/oamjms.2017.003
Abstrakt:	Background: Colorectal cancer (CRC) is one of the most common cancers worldwide. Microsatellite instability (MSI) is detected in about 15% of all colorectal cancers. CRC with MSI has particular characteristics such as improved survival rates and better prognosis. They also have a distinct sensitivity to the action of chemotherapy. Aim: The aim of the study was to detect microsatellite instability in a cohort of colorectal cancer Egyptian patients using the immunohistochemical expression of mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2). Material and Methods: Cases were divided into Microsatellite stable (MSS), Microsatellite unstable low (MSI-L) and Microsatellite unstable high (MSI-H). This Microsatellite stability status was correlated with different clinicopathological parameters. Results: There was a statistically significant correlation between the age of cases, tumor site & grade and the microsatellite stability status. There was no statistically significant correlation between the gender of patients, tumor subtype, stage, mucoid change, necrosis, tumor borders, lymphocytic response, lymphovascular emboli and the microsatellite stability status. Conclusion: Testing for MSI should be done for all colorectal cancer patients, especially those younger than 50 years old, right sided and high-grade CRCs.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu